Wolverine Trading
DNA icon

Wolverine Trading’s Ginkgo Bioworks DNA Stock Holding History

Wolverine Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$964K Buy
+72,900
New +$872K ﹤0.01% 2938
2025
Q2 		– Sell
-52,600
Closed -$322K – 4936
2025
Q1 		$322K Sell
52,600
-177,700
-77% -$1.81M ﹤0.01% 3443
2024
Q4 		$2.17M Buy
230,300
+2,400
+1% +$20.6K ﹤0.01% 1888
2024
Q3 		$1.84M Buy
227,900
+222,385
+4,032% +$2.23M ﹤0.01% 1763
2024
Q2 		$73.7K Buy
+5,515
New +$165K ﹤0.01% 4152
2024
Q1 		– Sell
-5,790
Closed -$391K – 4674
2023
Q4 		$391K Sell
5,790
-400
-6% -$24.5K ﹤0.01% 3201
2023
Q3 		$448K Buy
6,190
+1,260
+26% +$101K ﹤0.01% 2870
2023
Q2 		$357K Sell
4,930
-43
-0.9% -$2.54K ﹤0.01% 2920
2023
Q1 		$245K Sell
4,973
-2,082
-30% -$132K ﹤0.01% 3223
2022
Q4 		$477K Buy
7,055
+2,592
+58% +$238K ﹤0.01% 2371
2022
Q3 		$559K Sell
4,463
-57
-1% -$6.79K ﹤0.01% 2511
2022
Q2 		$452K Buy
+4,520
New +$551K ﹤0.01% 2642
2022
Q1 		– Sell
-3,598
Closed -$1.29M – 5608
2021
Q4 		$1.29M Buy
3,598
+1,115
+45% +$530K ﹤0.01% 2336
2021
Q3 		$1.21M Buy
+2,483
New +$1.21M ﹤0.01% 2750

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's DNA Position: Q2 2025 in Review

Wolverine Trading sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 11,654 shares — an estimated $71.3K sold.

Wolverine Trading first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $270K in Q4 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

  • Wolverine Trading reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,654 Ginkgo Bioworks shares in Q2 2025, an estimated $71.3K.
  • Wolverine Trading first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
  • Wolverine Trading's Ginkgo Bioworks position peaked at $270K in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.